pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Marketed
emapalumab
Gamifant (emapalumab-lzsg)
Hemophagocytic Lymphohistiocytosis
Sobi Inc
0
catalysts
Phase 1
emaretamig
emaretamig [INN]
Adenocarcinoma Of The Gastroesophageal Junction
$XNCR
Xencor Inc
0
catalysts
Phase 3
emestedastat
Xanamem (emestedastat)
Alzheimer's Disease
Actinogen Medical Ltd
0
catalysts
← prev
page 175 of 231
next →
131
Pain
89
Neurology
1
Phase 2
emicizumab
Hemlibra (emicizumab-kxwh)
Acquired Hemophilia A
Coagulation factor IX and X
Chugai Pharmaceutical Co Ltd
0
catalysts
Phase 1
emiltatug ledadotin
emiltatug ledadotin [INN]
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$DAWN
Day One Biopharmaceuticals, Inc.
0
catalysts
Phase 3
emixustat hydrochloride
Juvenile Macular Degeneration (Stargardt Disease)
Retinoid isomerohydrolase
Kubota Vision Inc
0
catalysts
Phase 2
emodepside
Onchocerciasis (River Blindness)
Bayer AG
0
catalysts
Phase 3
empasiprubart
Multifocal Motor Neuropathy
$ARGX
ARGENX SE
0
catalysts
Phase 2
emraclidine
Psychosis
$ABBV
AbbVie Inc.
0
catalysts
Phase 2
emrusolmin
emrusolmin [INN]
Multiple System Atrophy (Multi-System Degeneration)
$TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
0
catalysts
Phase 2
emugrobart
emugrobart [INN]
Obesity
F. Hoffmann-La Roche Ltd
0
catalysts
Phase 1
emunkitug
emunkitug [INN]
Cervical Cancer
HiFiBiO Therapeutics Inc
0
catalysts
Marketed
enalapril maleate
Enalapril Maleate Oceanside (enalapril maleate)
Congestive Heart Failure (Heart Failure)
Oceanside Pharmaceuticals Inc
0
catalysts
Marketed
enalaprilat
Enalaprilat (enalaprilat)
Hypertension
Dr. Reddy's Laboratories Ltd
0
catalysts
Phase 2
enamptcumab
eNamptor
Acute Respiratory Distress Syndrome
Aqualung Therapeutics Corp
0
catalysts
Marketed
enasidenib mesylate
Idhifa (enasidenib mesylate)
Refractory Acute Myeloid Leukemia
Bristol-Myers Squibb Co
0
catalysts
Phase 3
encaleret
Autosomal Dominant Hypocalcemia
$BBIO
BridgeBio Pharma, Inc.
0
catalysts
Phase 2
encoberminogene rezmadenovec
Refractory Angina
XyloCor Therapeutics Inc
0
catalysts
Phase 2
endoxifen
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$ATOS
ATOSSA THERAPEUTICS, INC.
0
catalysts
Phase 3
eneboparatide
Hypoparathyroidism
Alexion Pharmaceuticals Inc
0
catalysts
Phase 2
enekinragene inzadenovec
Osteoarthritis
$PCRX
Pacira BioSciences, Inc.
0
catalysts
Phase 2
engasertib
engasertib [INN]
Hereditary Hemorrhagic Telangiectasia (Osler–Weber–Rendu Disease)
Vaderis Therapeutics AG
0
catalysts
Phase 2
eniluracil
Metastatic Breast Cancer
Dihydropyrimidine dehydrogenase [NADP(+)]
$PCSA
Processa Pharmaceuticals, Inc.
0
catalysts
Phase 3
enlicitide decanoate
Heterozygous Familial Hypercholesterolemia (heFH)
$MRK
Merck & Co., Inc.
0
catalysts
Phase 2
enobosarm
Obesity
Androgen receptor
$VERU
VERU INC.
0
catalysts
Phase 2
enozertinib
enozertinib [INN]
Solid Tumor
$ORIC
Oric Pharmaceuticals, Inc.
0
catalysts
Marketed
ensifentrine
Ohtuvayre (ensifentrine)
Bronchiectasis
Phosphodiesterase 3
Phosphodiesterase 4
Verona Pharma Ltd
0
catalysts
pre_registration
ensitrelvir fumarate
Coronavirus Disease 2019 (COVID-19)
$SGIOF
SHIONOGI & CO LTD
0
catalysts
Marketed
entacapone
Entacapone AvKare (entacapone)
Parkinson's Disease
AvKare LLC
0
catalysts
Marketed
entecavir
Entecavir (entecavir)
Hepatitis B
Carlsbad Technology Inc
0
catalysts
